Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: outcomes from the 4-week maximal usage trial

被引：1
|
作者：
Paller, Amy [1 ]
Jett, John E. [2 ]
Hebert, Adelaide [3 ,4 ,5 ]
Brown, Philip M. [2 ]
Butners, Victoria [2 ]
Fitzgerald, Nancy [2 ]
Delgado, Marta [6 ]
Gonzalez, Mercedes E. [7 ]
Piscitelli, Stephen C. [2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] Dermavant Sci Inc, Morrisville, NC USA
[3] UTHealth McGovern, McGovern Sch Med, Houston, TX USA
[4] UTHealth McGovern, Childrens Mem Hermann Hosp, Houston, TX USA
[5] UTHealth McGovern Med Sch, Houston, TX USA
[6] RM Med Res Inc, Miami Lakes, FL USA
[7] Pediat Skin Res LLC, Miami, FL USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
atopic dermatitis; pediatrics; tapinarof; maximal usage trial;
D O I：
10.1093/bjd/ljad162.028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
406
引用
收藏
页数：2
相关论文
共 38 条
  • [1] Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: 4-week maximal use trial
    Paller, Amy
    Hebert, Adelaide A.
    Jett, John E.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [2] Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials
    Gold, Linda Stein
    Del Rosso, James
    Ehst, Benjamin D.
    Zirwas, Matthew J.
    Green, Lawrence J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Tallman, Anna M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [3] Tapinarof cream 1% once daily for the treatment of moderate-to-severe atopic dermatitis in children and adults: the pivotal phase III ADORING clinical program
    Eichenfield, L. F.
    Silverberg, J. I.
    Bissonnette, R.
    Tallman, A. M.
    Brown, P. M.
    Rubenstein, D. S.
    Piscitelli, S. C.
    Jett, J. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E136 - E136
  • [4] Tapinarof cream 1% once daily for the treatment of moderate-to-severe atopic dermatitis in children and adults: the pivotal phase III ADORING clinical programme
    Eichenfield, L. F.
    Silverberg, J. I.
    Bissonnette, R.
    Tallman, A. M.
    Brown, P. M.
    Rubenstein, D. S.
    Piscitelli, S. C.
    Jett, J. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E127 - E128
  • [5] Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial
    Bagel, Jerry
    Gold, Linda Stein
    Del Rosso, James
    Johnson, Sandy
    Yamauchi, Paul
    Brown, Philip M.
    Bhatia, Neal
    Moore, Angela Yen
    Tallman, Anna M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (05) : 936 - 944
  • [6] Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream
    Tschen, E
    Elewski, B
    Gorsulowsky, DC
    Pariser, DM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) : S9 - S14
  • [7] Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age
    Silverberg, Jonathan, I
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II17 - II18
  • [8] Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis
    Paller, Amy S.
    Gold, Linda Stein
    Soung, Jennifer
    Tallman, Anna M.
    Rubenstein, David S.
    Gooderham, Melinda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (03) : 632 - 638
  • [9] Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials
    Silverberg, Jonathan I.
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric L.
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (03) : 457 - 465
  • [10] Tapinarof Cream 1% Once Daily: Consistent Efficacy Across Disease Severity And Age Subgroups In The Treatment Of Adults And Children Down To 2 Years Of Age With Moderate To Severe Atopic Dermatitis
    Tallman, Anna
    Fonacier, Luz
    Boguniewicz, Mark
    Ohayon, Jason
    Brown, Phililp M.
    Rubenstein, David
    Silverberg, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
1234